Pulmonary Arterial Hypertension | Norton Healthcare

Indication: Pulmonary Arterial Hypertension

A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects with PAH via an Open-Label Extension (ADVANCE-extension)

Sub-indication: Pulmonary Arterial Hypertension (PAH)

Study Type: Drug Study

Principal Investigator: John McConnell, M.D.
Norton Pulmonary Specialists

Sponsor: Sponsor: UNITED THERAPEUTICS CORPORATION

Learn more at ClinicalTrials.gov

Email for more information: npsresearch@nortonhealthcare.org

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.